News & Updates
Filter by Specialty:
How well did radiographers manage during the COVID-19 outbreak?
In Singapore, diagnostic radiographers were able to cope with the high demands of the COVID-19 pandemic in terms of provision of information, supplies, and physical equipment, a survey shows. However, they were less prepared to manage human factors, such as mental health and staff morale.
How well did radiographers manage during the COVID-19 outbreak?
03 May 2023Clindamycin delivers in bacterial vaginosis
Use of a single dose of a new bioadhesive 2% clindamycin vaginal gel in the treatment of bacterial vaginosis appears to result in a rapid resolution of symptoms, with high acceptability among women, as reported in a study.
Clindamycin delivers in bacterial vaginosis
29 Apr 2023New ARIA technology improves CVD risk estimates in high-risk individuals with HIV
Researchers from the Chinese University of Hong Kong (CUHK) have developed an automatic retinal image analysis (ARIA) technology that utilizes machine learning to improve cardiovascular disease (CVD) risk estimates in people living with HIV (PLWH) who have cardiovascular (CV) risk factors.
New ARIA technology improves CVD risk estimates in high-risk individuals with HIV
29 Apr 2023Bivalent mRNA-1273.214 booster offers superior immunogenicity vs original vax
The bivalent mRNA-1273.214 booster vaccine provides superior immunogenicity compared with the original COVID-19 mRNA-1273 vaccine in a phase III study, according to an expert who presented at ECCMID 2023.
Bivalent mRNA-1273.214 booster offers superior immunogenicity vs original vax
27 Apr 2023SARS-CoV-2 infection poses heightened risk of diabetes
SARS-CoV-2 infection puts individuals at increased risk of developing diabetes, contributing to between 3 percent and 5 percent excess burden of diabetes at a population level, as reported in a study.
SARS-CoV-2 infection poses heightened risk of diabetes
26 Apr 2023EAGLE trials herald new era for uncomplicated UTI treatment
Oral gepotidacin, an investigational, first-in-class oral antibiotic with a novel mechanism of action, showed favourable signals for the treatment of uncomplicated urinary tract infections (uUTIs), according to the results of two phase III trials.